Pharmacokinetics of meperidine in healthy volunteers after short- and long-term exposure to high altitude

Journal of Clinical Pharmacology

Volumn 36, Issue 7, 1996, Pages 610-616

  Ritschel, Wolfgang A ^a   Paulos, Claudio ^b   Arancibia, Aquiles ^b   Pezzani, Marcela ^b   Agrawal, Mukul A ^a   Wetzelsberger, Klaus M ^c   Lücker, Peter W ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^c Institute of Clinical Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NORPETHIDINE; PETHIDINE; WATER;

ADULT; ALTITUDE; ALTITUDE DISEASE; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG PROTEIN BINDING; ERYTHROCYTE COUNT; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; NORMAL HUMAN; PHARMACOKINETICS;

EID: 0029744555     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04225.x     Document Type: Article

References (14)

1. Houghton IT, Chan K, Wong YC, Aun CST, Lau OW, Lowe DM: Pethidine pharmacokinetics after intramuscular dose: a comparison in Caucasian, Chinese, and Nepalese patients. Methods Find Exp Clin Pharmacol 1992;14:451-458.
2. Pugh LGCE: Physiological and medical aspects of the Himalayan scientific and mountaineering expedition, 1960-1961. Br Med J 1962;2:621-627.
3. Blume FD, Boyer SJ, Braverman LE, Cohen A, Dirkse J, Mordes JP: Impaired osmoregulation at high altitude: studies on Mt. Everest. JAMA 1984;252:524-526.
4. Houston CS: Mountain sickness. Sci Am 1992;267:58-62.
5. Sutton JR: Mountain sickness. Neurol Clin 1992;10:1015-1030.
6. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG: Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993;118:587-592.
7. Surks MI: Metabolism of human serum albumin in man during acute exposure to high altitude (14,000 ft). J Clin Invest 1966;45: 1442-1452.
8. Hannon JP, Shields JL, Harris CW: Effects of altitude on blood composition in women. J Appl Physiol 1977;26:540-547.
9. Ritschel WA, Shapiro-Jacobson M, Akileswaran R, Wetzelsberger K. Lücker PW: Meperidine uptake and binding to human blood ex vivo. Methods Find Exp Clin Pharmacol 1995;17:477-481.
10. Edwards DJ, Svensson CK, Visco JP, Lalka D: Clinical pharmacokinetics of pethidine. Clin Pharmacokinet 1982;7:421-433.
11. Ritschel WA: Pharmacokinetic aspects of analgesics. Methods Find Exp Clin Pharmacol 1982;4:479-487.
12. Ritschel WA: AUC-RPP: BASIC computer program for the compartment model independent pharmacokinetic analysis. Methods Find Exp Clin Pharmacol 1986;8:633-640.
13. Ritschel WA: RESID: A curve-fitting program to generate pharmacokinetic parameters. Presented at the International Symposium on Clinical Pharmacokinetics, Salzgitter-Ringelheim, July 20-21, 1975.
14. Ritschel WA: Binding of drugs to biological material. In: Handbook of Basic Pharmacokinetics. Fourth edition. Hamilton, IL: Drug Intelligence Publications, 1992;138-155.